These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7922982)

  • 1. Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer.
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Gallee MP; Hart AA; Müller M; Trimbos JB; Helmerhorst TJ
    Cancer; 1994 Oct; 74(8):2307-13. PubMed ID: 7922982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to human papillomavirus type 16 E7 related to clinicopathological data in patients with cervical carcinoma.
    Baay MF; Duk JM; Burger MP; Walboomers J; ter Schegget J; Groenier KH; de Bruijn HW; Stolz E; Herbrink P
    J Clin Pathol; 1995 May; 48(5):410-4. PubMed ID: 7629285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.
    Viladiu P; Bosch FX; Castellsagué X; Muñoz N; Escribà JM; Hamsíkova E; Hofmannova V; Guerrero E; Izquierdo A; Navarro C; Moreo P; Izarzugaza I; Ascunce N; Gili M; Muñoz MT; Tafur L; Shah KV; Vonka V
    J Clin Oncol; 1997 Feb; 15(2):610-9. PubMed ID: 9053484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum antibody against unfused recombinant E7 protein of human papillomavirus type 16 in cervical cancer patients.
    Fujii T; Matsushima Y; Yajima M; Sugimura T; Terada M
    Jpn J Cancer Res; 1995 Jan; 86(1):28-34. PubMed ID: 7737906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
    Silins I; Avall-Lundqvist E; Tadesse A; Jansen KU; Stendahl U; Lenner P; Zumbach K; Pawlita M; Dillner J; Frankendal B
    Gynecol Oncol; 2002 May; 85(2):333-8. PubMed ID: 11972397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients.
    Nindl I; Benitez-Bribiesca L; Berumen J; Farmanara N; Fisher S; Gross G; Lopez-Carillo L; Müller M; Tommasino M; Vazquez-Curiel A
    Arch Virol; 1994; 137(3-4):341-53. PubMed ID: 7524466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA.
    Onda T; Kanda T; Zanma S; Yasugi T; Watanabe S; Kawana T; Ueda K; Yoshikawa H; Taketani Y; Yoshiike K
    Int J Cancer; 1993 Jun; 54(4):624-8. PubMed ID: 8390409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: prognostic value of anti-E6 and/or anti-E7 antibodies.
    Baay MF; Duk JM; Groenier KH; Burger MP; de Bruijn HW; Hollema H; Stolz E; Herbrink P
    Cancer Immunol Immunother; 1997 Jun; 44(4):211-5. PubMed ID: 9222279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of antibody responses to human papillomavirus type 16 E7 in patients treated for cervical carcinoma.
    Baay MF; Duk JM; Burger MP; de Bruijn HW; Stolz E; Herbrink P
    J Med Virol; 1995 Mar; 45(3):342-7. PubMed ID: 7775959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent association of antibodies against human papillomavirus type 16 E1/E4 and E7 proteins with cervical cancer.
    Kanda T; Onda T; Zanma S; Yasugi T; Furuno A; Watanabe S; Kawana T; Sugase M; Ueda K; Sonoda T
    Virology; 1992 Oct; 190(2):724-32. PubMed ID: 1325704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.
    Fisher SG; Benitez-Bribiesca L; Nindl I; Stockfleth E; Muller M; Wolf H; Perez-Garcia F; Guzman-Gaona J; Gutierrez-Delgado F; Irvin W; Gissmann L
    Gynecol Oncol; 1996 Apr; 61(1):73-8. PubMed ID: 8626121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer.
    Heim K; Widschwendter A; Pirschner G; Wieland U; Awerkiew S; Christensen ND; Bergant A; Marth C; Höpfl R
    Am J Obstet Gynecol; 2002 Apr; 186(4):705-11. PubMed ID: 11967495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
    Spector ME; Sacco AG; Bellile E; Taylor JMG; Jones T; Sun K; Brown WC; Birkeland AC; Bradford CR; Wolf GT; Prince ME; Moyer JS; Malloy K; Swiecicki P; Eisbruch A; McHugh JB; Chepeha DB; Rozek L; Worden FP
    Clin Cancer Res; 2017 Jun; 23(11):2723-2729. PubMed ID: 27872102
    [No Abstract]   [Full Text] [Related]  

  • 14. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
    Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
    J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
    Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
    Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of antibodies to L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls.
    Köchel HG; Monazahian M; Sievert K; Höhne M; Thomssen C; Teichmann A; Arendt P; Thomssen R
    Int J Cancer; 1991 Jul; 48(5):682-8. PubMed ID: 1649138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of antibodies to the E4 or E7 proteins of human papillomaviruses (HPV) in human sera by western blot analysis: type-specific reaction of anti-HPV 16 antibodies.
    Jochmus I; Bouwes Bavinck JN; Gissmann L
    Mol Cell Probes; 1992 Aug; 6(4):319-25. PubMed ID: 1326715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.
    Sasagawa T; Inoue M; Tanizawa O; Yutsudo M; Hakura A
    Jpn J Cancer Res; 1992 Jul; 83(7):705-13. PubMed ID: 1325428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to the E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population.
    Müller M; Viscidi RP; Ulken V; Bavinck JN; Hill PM; Fisher SG; Reid R; Munoz N; Schneider A; Shah KV
    J Invest Dermatol; 1995 Jan; 104(1):138-41. PubMed ID: 7798632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later.
    Lehtinen M; Pawlita M; Zumbach K; Lie K; Hakama M; Jellum E; Koskela P; Luostarinen T; Paavonen J; Pukkala E; Sigstad E; Thoresen S; Dillner J
    Am J Obstet Gynecol; 2003 Jan; 188(1):49-55. PubMed ID: 12548195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.